IBM workers will be able to use the renowned Watson Supercomputer to find the most effective oncology drugs and clinical trials for their specific cancers, the tech giant announced.

The computer giant announced yesterday that its workers will be able to use the supercomputer technology starting in January 2017. The company stressed that the decision would help the needy.

Kyu Rhee, chief health officer at IBM Watson Health, said, “For anyone receiving the diagnosis, or supporting a loved one through it, cancer can be overwhelming. With this first-ever U.S. rollout of the technology, the full breadth and depth of Watson’s services can benefit an entire population of individuals who need them.”

However, the computer giant didn’t specify how many of its workers in the United States will receive the benefit. The company has nearly 377,000 workers worldwide.

Pushing into health care, IBM noted that different types of cancer can mutate in diverse ways and can be driven by a range of genetic factors. Thus, certain treatments can prove to be more effective for some cancer patients than for others.

The Watson Health unit of IBM also has ambitious goals beyond oncology. Earlier this week, it announced a global collaboration with Siemens to track population health metrics.